Dr. Ryan Guest, PhD.

Non-Executive Director

Dr. Ryan Guest is a highly accomplished leader in the field of advanced therapy medicinal products (ATMPs), with over 25 years of experience in cell therapy development, manufacturing, and strategic business growth. As a Company Director at ImmunoKey, Ryan provides invaluable guidance on strategy, direction, and operational excellence, ensuring the company remains at the forefront of innovation in CAR T-cell therapies for solid tumours.

Ryan co-founded Immetacyte, leading development through to acquisition and contributing to strategic leadership thereafter. He is currently a Senior CMC Translation Consultant at Exmoor Pharma.

Ryan is a recognized expert in GMP manufacturing of CAR T-cell therapies, having developed scalable production platforms that have been implemented in global Phase III clinical trials, giving him a deep understanding of the technical and regulatory challenges in cell therapy manufacturing.